Dr. Gehrke has more than 20 years of experience within CMC and bioanalytical from multiple early-stage Pharma companies, various roles within a CRO, and Regulatory CMC oversight of commercial products at a medium size Pharma company. His CMC responsibilities have included discovery through commercialization activities including drug-device combination products. Dr. Gehrke’s most recent roles, prior to joining Dunn Regulatory Associates, include Principal Regulatory Affairs CMC specialist at Upsher-Smith Laboratories, LLC and Sr. Director of CMC for Proximagen, LLC. He received a Ph.D. in Analytical Chemistry from Missouri University of Science and Technology.